Public Health Emergency of International Concern

Hybribio returns to Medlab Middle East 2023

Retrieved on: 
Tuesday, January 17, 2023
Transfer, HPV, Public Health Emergency of International Concern, COVID-19, Colorectal cancer, Laboratory, Cervical cancer, Monkeypox, Methylation, STD, Public health emergency, PCR, Bladder cancer, Monkeypox virus, World Trade Center, Thalassemia, PHEIC, Vaccine

GUANGZHOU, China, Jan. 17, 2023 /PRNewswire/ -- Medlab Middle East 2023 will be held at the World Trade Centre, Dubai, UAE from February 6 to 9.

Key Points: 
  • GUANGZHOU, China, Jan. 17, 2023 /PRNewswire/ -- Medlab Middle East 2023 will be held at the World Trade Centre, Dubai, UAE from February 6 to 9.
  • Due to the COVID-19 pandemic, Hybribio (300639.SZ) was absent from Medlab Middle East for the last three years.
  • This year, Hybribio returns to the Medlab Middle East with varieties of cutting-edge in-vitro diagnostic products and latest nucleic acid molecular testing solutions, covering HPV, STD, thalassemia, methylation (cervical cancer, bladder cancer, colorectal cancer) etc.
  • Hybribio (300639.SZ) looks forward to meeting you at the Medlab Middle East 2023 and sincerely invites you to visit our booth to explore the future of nucleic acid testing!

Hybribio returns to Medlab Middle East 2023

Retrieved on: 
Tuesday, January 17, 2023
Transfer, HPV, Public Health Emergency of International Concern, COVID-19, Colorectal cancer, Laboratory, Cervical cancer, Monkeypox, Methylation, STD, Public health emergency, PCR, Bladder cancer, Monkeypox virus, World Trade Center, Thalassemia, PHEIC, Vaccine

GUANGZHOU, China, Jan. 17, 2023 /PRNewswire/ -- Medlab Middle East 2023 will be held at the World Trade Centre, Dubai, UAE from February 6 to 9.

Key Points: 
  • GUANGZHOU, China, Jan. 17, 2023 /PRNewswire/ -- Medlab Middle East 2023 will be held at the World Trade Centre, Dubai, UAE from February 6 to 9.
  • Due to the COVID-19 pandemic, Hybribio (300639.SZ) was absent from Medlab Middle East for the last three years.
  • This year, Hybribio returns to the Medlab Middle East with varieties of cutting-edge in-vitro diagnostic products and latest nucleic acid molecular testing solutions, covering HPV, STD, thalassemia, methylation (cervical cancer, bladder cancer, colorectal cancer) etc.
  • Hybribio (300639.SZ) looks forward to meeting you at the Medlab Middle East 2023 and sincerely invites you to visit our booth to explore the future of nucleic acid testing!

Integrated DNA Technologies Launches Complete NGS Library Preparation Solution for Monkeypox

Retrieved on: 
Tuesday, August 30, 2022
Science, Other Science, Biotechnology, Research, General Health, Health, Infectious Diseases, Other Health, Monkeypox virus, ISO, Technology, Integrated DNA Technologies, Synthetic biology, Cancer, RNA, Program, Research, Arizona State University, Agriculture, YouTube, NGS, Solution, Lists of people executed in the United States, RNA interference, World, Infection, Pressure, LinkedIn, DNA, Workflow, Real-time, Library, Multimedia, Public health emergency, Public Health Emergency of International Concern, Triangle Park (Quezon City), GMP, PCR, Monkeypox, Instagram, CRISPR, ITRS, Twitter, Integration, RUO, Face, IDT, Genomics, Industry, Omicron, World Health Organization, Pharmaceutical industry, Online shopping, Vaccine, Facebook, Delta

Committed to providing quality products to researchers working on the cutting edge of scientific discovery, Integrated DNA Technologies' newly launched xGen Monkeypox Virus Amplicon Panel is a complete next generation sequencing (NGS) library preparation solution that supports the genotyping of MPXV within a sample.

Key Points: 
  • Committed to providing quality products to researchers working on the cutting edge of scientific discovery, Integrated DNA Technologies' newly launched xGen Monkeypox Virus Amplicon Panel is a complete next generation sequencing (NGS) library preparation solution that supports the genotyping of MPXV within a sample.
  • (Photo: Business Wire)
    The xGen Monkeypox Virus Amplicon Panel is a complete NGS library preparation solution that supports the genotyping of MPXV within a sample.
  • IDT tested the panel with commercially available monkeypox DNA and demonstrated coverage of positions 6760190,905 (inverted-terminal repeats (ITRs) not included).
  • In addition to releasing its monkeypox virus NGS panel, IDT also is offering custom and pre-designed qPCR solutions for monkeypox research needs.

T2 Biosystems to Explore Potential to Develop Rapid Molecular Diagnostic Test for Monkeypox Virus

Retrieved on: 
Tuesday, August 9, 2022
FDA, U.S. Securities and Exchange Commission, Monkeypox, Public health, World Health Organization, Laboratory, CEO, GLOBE, International Health Regulations, Diagnosis, Failure, Private Securities Litigation Reform Act, SEC, Growth, Disease, Public Health Emergency of International Concern, Public health emergency, Rash, Health, Patient, CDC, LDT, Contract, Virus, NASDAQ, Infection, World, Monkeypox virus, Smallpox, BioSystems, Orthopoxvirus, Adoption, Vaccine

LEXINGTON, Mass., Aug. 09, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today plans to explore the potential to develop a rapid molecular diagnostic test for detection of the monkeypox virus, including technical and commercial feasibility.

Key Points: 
  • LEXINGTON, Mass., Aug. 09, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today plans to explore the potential to develop a rapid molecular diagnostic test for detection of the monkeypox virus, including technical and commercial feasibility.
  • Monkeypox is a rare disease caused by infection with the monkeypox virus that is part of the orthopoxvirus family of viruses, which also contains smallpox.
  • A rapid and accurate diagnosis of monkeypox is essential to expedite treatment and to limit exposure and spread of the disease.
  • Given the urgent nature of the monkeypox virus, and the potential for global transmission, we have communicated with the FDA and CDC and we are exploring the potential to develop and commercialize a test for the monkeypox virus.

AHF to L.A. County: Declare a Monkeypox ‘State of Emergency!’

Retrieved on: 
Friday, July 29, 2022
Public Policy, Government, State, Local, Public Policy, Health, Infectious Diseases, Consumer, LGBTQ+, Advocacy Group Opinion, Public Health Emergency of International Concern, Monkeypox virus, Public health, Sex, Los Angeles County Department of Public Health, Epidemic, Monkeypox, Emergency, AHF, Weeping Angel, Facebook, AIDS, AIDS Healthcare Foundation, Public, Man, Public health emergency, Infection, City

AIDS Healthcare Foundation ( AHF ) today is calling on the Los Angeles County Department of Public Health to immediately declare a state of emergency on monkeypox.

Key Points: 
  • AIDS Healthcare Foundation ( AHF ) today is calling on the Los Angeles County Department of Public Health to immediately declare a state of emergency on monkeypox.
  • The Los Angeles County Department of Public Health should mobilize everything in its toolbox to address monkeypox and declaring a state of emergency is a crucial next step to address monkeypox.
  • Since May, the monkeypox virus erupted into several epidemics outside of Africa, where it has long been considered endemic in a handful of countries.
  • To learn more about AHF, please visit our website: www.aidshealth.org , find us on Facebook: www.facebook.com/aidshealth , follow us @aidshealthcare or subscribe to our AHF podcast AHFter Hours.

Monkeypox Emergency Declaration a Step in Right Direction, says AHF

Retrieved on: 
Tuesday, July 26, 2022
Infectious Diseases, Advocacy Group Opinion, Public Policy, Government, Healthcare Reform, Philanthropy, AIDS, General Health, Health, Foundation, Public Safety, HIV/AIDS, University, Disasters Emergency Committee, Awareness, Instagram, Twitter, Human, World, Research, Risk, Monkeypox, AHF, PHEIC, Epidemiology, Public Health Emergency of International Concern, Facebook, Disease, AIDS, AIDS Healthcare Foundation, Democratic republic, Pressure, Man, Public health emergency, International Health Regulations, WHO, Pharmaceutical industry, Vaccine, Central Africa

While long overdue, AIDS Healthcare Foundation acknowledged the World Health Organizations decision yesterday to declare the global monkeypox outbreak a Public Health Emergency of International Concern.

Key Points: 
  • While long overdue, AIDS Healthcare Foundation acknowledged the World Health Organizations decision yesterday to declare the global monkeypox outbreak a Public Health Emergency of International Concern.
  • The world has needed this declaration for at least the last ten weeks, and weve called for it for the last month.
  • Most governments do not inform, react or properly respond to an outbreak if the WHO has not labeled a disease a PHEIC.
  • Monkeypox cases rose exponentially worldwide in the past month; however, some countries have struggled with it for decades without international attention or aid.

AHF: Monkeypox Vaccine Access Must Be Guided by Global Equity, Inclusion

Retrieved on: 
Tuesday, July 26, 2022
LGBTQ+, Professional Services, Public Policy, Government, Infectious Diseases, Healthcare Reform, Foundation, Philanthropy, DEI (Diversity, Equity and Inclusion), Medical Supplies, Consumer, COVID-19, AIDS, Health, Public Policy, Advocacy Group Opinion, Other Policy Issues, Pharmaceutical, Monkeypox virus, Sex, Los Angeles Times, Associated Press, AP, World, MUST, Monkeypox, AHF, PHEIC, COVID-19, Public health, World Health Organization, Associated, News, Public Health Emergency of International Concern, Facebook, Reuters, AIDS, COVID, AIDS Healthcare Foundation, Man, International, Public health emergency, Infection, WHO, Vaccine, Pharmaceutical industry

AIDS Healthcare Foundation ( AHF ) today sharply criticized the World Health Organization (WHO) and the collective emerging and sluggish global response to monkeypox.

Key Points: 
  • AIDS Healthcare Foundation ( AHF ) today sharply criticized the World Health Organization (WHO) and the collective emerging and sluggish global response to monkeypox.
  • Associated Press (via L.A. Times) reported Saturday on the WHOs decision this weekend to finally declare monkeypox a Public Health Emergency of International Concern (PHEIC).
  • Although countries including Britain, Canada, Germany and the U.S. have ordered millions of vaccine doses, none has gone to Africa.
  • Given the rapid, uncontrolled spread of this virus, WHO should immediately declare monkeypox what it really is: a pandemic.

WHO Must Declare Monkeypox a Pandemic, say AHF, MPact and Mexican NGOs

Retrieved on: 
Thursday, July 21, 2022
Other Health, LGBTQ+, Public Safety, Consumer, White House, Federal Government, Infectious Diseases, Public Policy, Other Policy Issues, COVID-19, AIDS, FDA, Health, Public Policy, Government, HIV/AIDS, World, University, Education, Awareness, Sex, Instagram, Twitter, Â, Government, Research, Monkeypox, AHF, PHEIC, Public health, World Health Organization, LGBT, Public Health Emergency of International Concern, Facebook, Disease, AIDS, AIDS Healthcare Foundation, Sex education, Man, Internet, Public health emergency, HIV, WHO, Non-governmental organization, Vaccine, Pharmaceutical industry

Monkeypox has spread to over 60 countries where it is not endemic, resulting in more than 14,100 global cases .

Key Points: 
  • Monkeypox has spread to over 60 countries where it is not endemic, resulting in more than 14,100 global cases .
  • Delays are a repeat of COVID-19its clear by any logical definition that monkeypox is a pandemic.
  • Considering the resources required to provide safe and effective vaccines to gay, bi, trans, and queer people, we need WHO to declare monkeypox a PHEIC.
  • Previously, AHF issued two recent statements with both urging the WHO to declare monkeypox a PHEIC.

STATEMENT - Update on monkeypox in Canada - June 27, 2022

Retrieved on: 
Monday, June 27, 2022
Diagnosis, Women's Emergency Committee to Open Our Schools, Government of Canada, PHEIC, Research, Greater Sullivan County Public Health Network, Disease, Government, Monkeypox virus, National Microbiology Laboratory, IPC, Committee, Infection, NML, Health Canada, Awareness, World, Risk, Monkeypox, Public Health Emergency of International Concern, NACI, National Advisory Committee on Immunization, World Health Organization, International Health Regulations, Public Health Agency of Canada, Public Health Agency, Public health, IHR, PHAC, Vaccine, News, Public health emergency, WHO, Animal, Medical device, Immunization, Health

The Public Health Agency of Canada (PHAC) is issuing this statement to provide an update on its ongoing response to monkeypox.

Key Points: 
  • The Public Health Agency of Canada (PHAC) is issuing this statement to provide an update on its ongoing response to monkeypox.
  • The Government of Canada took immediate action upon the confirmation of the first cases in Canada.
  • OTTAWA, ON, June 27, 2022 /CNW/ - On June 23, 2022, the World Health Organization (WHO) Director General convened its International Health Regulations (IHR) Emergency Committee to discuss the multi-country outbreak of monkeypox.
  • Since the outset of the monkeypox outbreak, the Public Health Agency of Canada (PHAC) has been working with domestic and international partners to protect the health of everyone in Canada.

Pictor Receives CE Mark for its PictArray™ SARS-CoV-2 Antibody Test, Indicating Whether Patients Require COVID-19 Booster

Retrieved on: 
Wednesday, June 22, 2022
Medical Supplies, Health, Infectious Diseases, Other Health, Pharmaceutical, Biotechnology, Lazarus, Antibody, Diagnosis, Urban economics, Public health, Infection, COVID-19, Public health emergency, World, CE, IVDD, NZD, CEO, CE marking, European Economic Area, Vaccination, ANZ, Severe acute respiratory syndrome coronavirus 2, ELISA, World Health Organization, Twitter, Patient, NP, SP, Public Health Emergency of International Concern, Vaccine, Pictor, MD

The CE Mark will allow the company to market its COVID-19 antibody test in Europe and gain regulatory approval in Southeast Asia.

Key Points: 
  • The CE Mark will allow the company to market its COVID-19 antibody test in Europe and gain regulatory approval in Southeast Asia.
  • Receiving CE registration enables Pictor to establish a footprint with partner laboratories and research bodies within Europe which is an important market for us, said Howard Moore, CEO of Pictor.
  • It will also indicate whether at-risk patients have failed to mount a detectable antibody response despite vaccination or infection (SP and NP negative).
  • The companys lead product, PictArray SARS-CoV-2 IgG ELISA Kit, enables more informed clinical intervention to manage the threat of COVID-19.